1/
【💉JAPAN TAKEDA Launch "TAK-888" to Combat COVID19💉】
🇯🇵JAPAN Takeda Pharmaceutical Announces a Plasma-Derived Coronavirus Therapy
Plasma-derived therapies have proven effective in the treatment of severe acute viral respiratory infections.
(continue)
【💉JAPAN TAKEDA Launch "TAK-888" to Combat COVID19💉】
🇯🇵JAPAN Takeda Pharmaceutical Announces a Plasma-Derived Coronavirus Therapy
Plasma-derived therapies have proven effective in the treatment of severe acute viral respiratory infections.
(continue)
2/
Takeda will initiate a program to test plasma-derived therapies (PDT) in high-risk individuals who might die from COVID19.
These therapies were successfully used as last-resort treatments in prior outbreaks of SARS, MERS and Ebola.
(continue)
Takeda will initiate a program to test plasma-derived therapies (PDT) in high-risk individuals who might die from COVID19.
These therapies were successfully used as last-resort treatments in prior outbreaks of SARS, MERS and Ebola.
(continue)
3/
Takeda's program, called "TAK-888", will ultimately use a type of blood plasma from people who have successfully recovered from the novel coronavirus infections.
It is believed these donors will have developed antibodies to the virus, hence, therapies derived from...
Takeda's program, called "TAK-888", will ultimately use a type of blood plasma from people who have successfully recovered from the novel coronavirus infections.
It is believed these donors will have developed antibodies to the virus, hence, therapies derived from...
4/
... their plasma should help others to fight it off.
GO TAKEDA!!!!!!!
Proud our Japan Technology...!!!
businesswire.com/news/home/2020…
... their plasma should help others to fight it off.
GO TAKEDA!!!!!!!
Proud our Japan Technology...!!!
businesswire.com/news/home/2020…
